Orthopedic News

October 02, 2004

Vioxx Recall Affects Arthritis Sufferers, Debate Over Osteoporosis Drugs

"A day after the popular arthritis drug Vioxx was yanked from the market because of safety concerns, doctors, patients and insurance companies were busy trying to figure out the next step."

"As women search beyond hormone treatments for ways to prevent osteoporosis, a debate is raging over which of two leading drugs that slow bone loss, Fosamax and Actonel, is better."

Posted by news editor | Filed under: Arthritis

More News Topics:
Breast Cancer      Alternative Medicine      Infectious Disease       Eating Disorders       Sleep      Allergies      Neurological Disorders      Senior Health       Heart Health      Mental Health       Autoimmune Disorders       Women's Health
All content published on HealthDiaries.com is provided for informational and educational purposes only. HealthDiaries.com does not provide medical advice, diagnosis or treatment. The site and its services are not a substitute for professional medical advice and treatment. Always seek the advice of your doctor before making any changes to your health routine or treatment.

Copyright © 2004-2005 HealthDiaries.com. All rights reserved.